Bliss GVS Pharma Ltd
NSE: BLISSGVS BSE: 506197
₹216.26
(-3.03%)
Wed, 11 Mar 2026, 05:53 pm
Market Cap23.56B
PE Ratio21.26
Dividend0.45
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1984
- Bliss GVS Pharma Limited was incorporated on 11th December, as public limited company and promoted by Mr Gautam Ashra.
2004
- Public shareholders of the company received an open offer by the Fedex Securities Ltd on behalf of Shri M G Wagle, Shri Gautam R Ashra & Shri Shibroor N Kamath.
2005
- Board of directors of the company had recommended the issue of bonus shares of 2 shares for every 5 shares.
2006
- Board of directors of the company had approved to takeover GVS Lab and to change the name of the company from 'Bliss Chemicals & Pharmaceuticals India Ltd' to 'Bliss GVS Pharma Ltd'
- Gautam Ashra, promoter director of the company, sold 104,200 equity shares of the company for average sale price of Rs. 52.02 at the exchange.
2007
- The board of the company had approved to take over GVS Labs of S N Kamath for a consideration of Rs 160 million
- The company had received an order of Rs. 25.00 crores for supply of Anti malarial Drugs for African Countries
- The company set up its new manufacturing unit for tablets, dry syrup, oral suspension and suppository pessaries in the existing manufacturing facility at Palghar in Maharashtra.
2008
- Members at the extra ordinary general meeting of the company had approved split of shares of face Value of Rs 10 each into face value of Rs 1 each
- The company had fixed 18th March 2008 as the record date for the split of the equity shares of the company
- The Company has issued Bonus Shares in the Ratio of 3:5.
2009
- Company has received an Award from Pharmexcil
- Company successfully completed its 25th year of operations.
2010
- Company has signed a Joint Venture Agreement with Kuwait
- Mr. S N. Kamath, Promoter & Managing Director of the company has received a National Award -2009 from Government of India
- Registered Office of the Company has been shifted from 6/29-A, Udit Mittal Industry, Andheri Kurla Road, Andheri - East, Mumbai - 400 059 to 102, Hyde Park, Sakivihar Road, Andheri - East, Mumbai - 400 072
2011
- Bliss GVS Pharma Ltd recommended of 30% Dividend i.e. Rs. 0.30 per equity share
2012
- Company has acquired 70% management stake in the Company M/s. Kremoint Pharma Private Limited
2013
- Bliss GVS Pharma Ltd recommended a dividend of 40%
- Bliss GVS receives recognition for its Research & Development Lab from the Department of Scientific & Industrial Research (DSIR), Government of India.
2014
- Bliss GVS is named in Moneylife magazine's 'Wealth Creators 2004-2013' list
- Bliss GVS Wins - Outstanding Exports Award.
2015
- Bliss GVS Pharma wins Healthcare Services contract in Kenya
2016
- Bliss GVS Pharma arm wins $111 mn contract from Kenyan firm.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800